Amgen Sues Hospira Over Biosimilar Info, Notice
Amgen Inc. on Friday sued Hospira Inc. in Delaware federal court for allegedly violating information-sharing and advance-notice provisions of the Biologics Price Competition and Innovation Act, adding to a flurry of...To view the full article, register now.
Already a subscriber? Click here to view full article